Bristol, Sanofi Pledge To Defend Plavix Patent In Face Of Potential “At Risk” Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA grants final approval to Apotex’ ANDA for the antithrombotic, fueling speculation over timing of generic entry.